X-71224497-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 5P and 5B. PM1PP2PP3_ModerateBP6BS2

The NM_000166.6(GJB1):​c.790C>T​(p.Arg264Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,198,038 control chromosomes in the GnomAD database, including 1 homozygotes. There are 8 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R264L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000029 ( 1 hom. 8 hem. )

Consequence

GJB1
NM_000166.6 missense

Scores

5
6
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:1

Conservation

PhyloP100: 2.61

Publications

7 publications found
Variant links:
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
GJB1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease X-linked dominant 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
  • X-linked progressive cerebellar ataxia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a chain Gap junction beta-1 protein (size 282) in uniprot entity CXB1_HUMAN there are 184 pathogenic changes around while only 11 benign (94%) in NM_000166.6
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 135 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Charcot-Marie-Tooth disease X-linked dominant 1, X-linked progressive cerebellar ataxia.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.866
BP6
Variant X-71224497-C-T is Benign according to our data. Variant chrX-71224497-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 155727.
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000166.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJB1
NM_000166.6
MANE Select
c.790C>Tp.Arg264Cys
missense
Exon 2 of 2NP_000157.1
GJB1
NM_001097642.3
c.790C>Tp.Arg264Cys
missense
Exon 2 of 2NP_001091111.1
GJB1
NM_001440770.1
c.790C>Tp.Arg264Cys
missense
Exon 3 of 3NP_001427699.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJB1
ENST00000361726.7
TSL:1 MANE Select
c.790C>Tp.Arg264Cys
missense
Exon 2 of 2ENSP00000354900.6
GJB1
ENST00000374029.2
TSL:5
c.790C>Tp.Arg264Cys
missense
Exon 2 of 2ENSP00000363141.1
GJB1
ENST00000447581.2
TSL:5
c.790C>Tp.Arg264Cys
missense
Exon 3 of 3ENSP00000407223.2

Frequencies

GnomAD3 genomes
AF:
0.00000897
AC:
1
AN:
111495
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000571
AC:
9
AN:
157521
AF XY:
0.0000199
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000157
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000244
Gnomad FIN exome
AF:
0.0000705
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000247
GnomAD4 exome
AF:
0.0000285
AC:
31
AN:
1086543
Hom.:
1
Cov.:
31
AF XY:
0.0000226
AC XY:
8
AN XY:
353907
show subpopulations
African (AFR)
AF:
0.0000382
AC:
1
AN:
26146
American (AMR)
AF:
0.000176
AC:
6
AN:
34110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19158
East Asian (EAS)
AF:
0.000168
AC:
5
AN:
29785
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52565
European-Finnish (FIN)
AF:
0.0000254
AC:
1
AN:
39300
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4120
European-Non Finnish (NFE)
AF:
0.0000203
AC:
17
AN:
835679
Other (OTH)
AF:
0.0000219
AC:
1
AN:
45680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000897
AC:
1
AN:
111495
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33665
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30628
American (AMR)
AF:
0.00
AC:
0
AN:
10483
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3503
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2667
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6023
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53106
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000834
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000332
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:1Uncertain:1
Oct 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Northcott Neuroscience Laboratory, ANZAC Research Institute
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Charcot-Marie-Tooth disease Uncertain:1
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Charcot-Marie-Tooth Neuropathy X Uncertain:1
Mar 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 264 of the GJB1 protein (p.Arg264Cys). This variant is present in population databases (rs587777879, gnomAD 0.03%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 12402337, 25802885, 28768847, 33105617). ClinVar contains an entry for this variant (Variation ID: 155727). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

not provided Benign:1
Sep 05, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.54
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.21
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.87
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Uncertain
0.74
D
MutationAssessor
Benign
0.69
N
PhyloP100
2.6
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.69
N
REVEL
Uncertain
0.64
Sift
Benign
0.044
D
Sift4G
Uncertain
0.016
D
Polyphen
0.99
D
Vest4
0.45
MutPred
0.83
Loss of solvent accessibility (P = 0.0404)
MVP
1.0
MPC
1.4
ClinPred
0.080
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.23
gMVP
0.74
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587777879; hg19: chrX-70444347; API